Predicted to enable DNA binding activity and protein heterodimerization activity. Predicted to be part of CHRAC. Predicted to be active in nucleus. Orthologous to human CHRAC1 (chromatin accessibility complex subunit 1). [provided by Alliance of Genome Resources, Apr 2022]